TCL Archive Aranesp Approval Introduces Competition To $1.8 Billion U.S. Cancer Anemia Market August 2, 2002
TCL Archive Five Year Survival Up To 48 Percent; DeVita Has “No Doubt” It Is Really Over 50 Percent Now December 2, 1983
TCL Archive In Brief: Panel to Meet Jan. 30 In Los Angeles; Fate Of Proposed Urologic Group Depends On Budget January 10, 1986
